Site içinde arama yapın | SPORTIVO Network

rishika_2003 bir ses eklendi Other
2026-05-29 09:26:12

Cancer Treatment Drugs Market to Reach USD 359.83 Billion by 2032 Driven by Immunotherapy and Precision Oncology Advancements
According to a report by Intel Market Research, the global cancer treatment drugs market was valued at USD 193.12 billion in 2024 and is projected to grow from USD 211.45 billion in 2025 to USD 359.83 billion by 2032, exhibiting a CAGR of 9.5% during the forecast period. The market is witnessing strong growth due to the rising global burden of cancer, increasing adoption of targeted therapies...

0 Yorumlar 0 hisse senetleri 548 Views 0 önizleme

Please log in to like, share and comment!
Kumud bir ses eklendi Health
2026-04-07 12:36:34

Bladder Cancer Market to Reach USD 4.1 Billion by 2031 | CAGR 6.7%
According to a newly published market research report by 24LifeSciences, global bladder cancer market was valued at USD 2.6 billion in 2024 and is projected to reach USD 4.1 billion by 2031, growing at a compound annual growth rate (CAGR) of 6.7% during the forecast period 2025-2031. Bladder cancer remains one of the most prevalent urological malignancies worldwide, with non-muscle invasive...

0 Yorumlar 0 hisse senetleri 3K Views 0 önizleme

Please log in to like, share and comment!
Kumud bir ses eklendi Health
2026-04-09 09:44:26

Global Endometrial Cancer Treatment Market Insights & Growth Trends | CAGR 4.5% (2025–2031)
According to a newly published market research report by 24LifeSciences, global endometrial cancer treatment market was valued at USD 21,380 million in 2024 and is projected to reach USD 28,790 million by 2031, growing at a compound annual growth rate (CAGR) of 4.5% during the forecast period 2025–2031. Endometrial cancer, classified under gynecologic malignancies, originates in the...

1

0 Yorumlar 0 hisse senetleri 2K Views 0 önizleme

Please log in to like, share and comment!
Kumud bir ses eklendi Health
2026-04-09 09:47:12

Global Endometrial Cancer Treatment Market Insights & Growth Trends | CAGR 4.5% (2025–2031)
According to a newly published market research report by 24LifeSciences, global endometrial cancer treatment market was valued at USD 21,380 million in 2024 and is projected to reach USD 28,790 million by 2031, growing at a compound annual growth rate (CAGR) of 4.5% during the forecast period 2025–2031. Endometrial cancer, classified under gynecologic malignancies, originates in the...

1

0 Yorumlar 0 hisse senetleri 2K Views 0 önizleme

Please log in to like, share and comment!
naznins407 bir ses eklendi Health
2026-03-04 08:38:25

Market Outlook 2025–2031: Future of Sarcoma Drug Development
Orphan drug designation is supporting market expansion.Regulatory incentives encourage rare cancer drug development.Faster approvals enhance product commercialization opportunities The Sarcoma Drugs Market is projected to witness steady growth, registering a CAGR of 7.9% from 2025 to 2031. The market size is expected to expand from US$ XX million in 2024 to US$ XX million by 2031, driven by...

1

0 Yorumlar 0 hisse senetleri 8K Views 0 önizleme

Please log in to like, share and comment!
stephengrey169 bir ses eklendi Other
2026-04-08 15:06:05

Pioneering Therapeutic Frontiers: Cancer Immunotherapy Market Growth, Opportunities, and Strategic Analysis by 2031
The Cancer Immunotherapy Market is at the forefront of revolutionizing cancer care, offering transformative treatment options that harness the body’s immune system to combat malignancies more effectively. According to industry projections, the Cancer Immunotherapy Market size is expected to reach US$ 319,946 million by 2031, with the market anticipated to register a compound annual growth...

0 Yorumlar 0 hisse senetleri 2K Views 0 önizleme

Please log in to like, share and comment!
naznins407 bir ses eklendi Health
2026-03-05 05:15:07

Sarcoma Drugs Market Forecast 2025–2031: Opportunities in Rare Cancer Therapies
The rising demand for innovative cancer therapies is fueling the Sarcoma Drugs Market globally. Researchers are focusing on immunotherapy and combination therapies to improve treatment effectiveness. Such developments are strengthening the oncology drug pipeline. The Sarcoma Drugs Market is expected to register a CAGR of 7.9% from 2025 to 2031, with the market size expanding from US$ XX million...

0 Yorumlar 0 hisse senetleri 8K Views 0 önizleme

Please log in to like, share and comment!